Paying user area
Try for free
Thermo Fisher Scientific Inc. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Analysis of Profitability Ratios
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Thermo Fisher Scientific Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
Thermo Fisher Scientific Inc., selected items from income statement, long-term trends
US$ in millions
12 months ended: | Revenues | Operating income | Net income attributable to Thermo Fisher Scientific Inc. |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The analysis of the financial data reveals several notable trends and patterns over the period presented.
- Revenues
- There is a general upward trend in revenues from 2005 to 2024, starting at $2,633 million and reaching $42,879 million in 2024. Revenues increased significantly between 2006 and 2007, growing from $3,792 million to $9,746 million, indicating a period of rapid expansion. From 2007 to 2014, revenues grew steadily but at a slower pace, with occasional fluctuations such as a decline between 2013 ($13,090 million) and 2014 ($16,890 million). The growth accelerated again from 2014 to 2021, peaking at $39,211 million in 2021. Post-2021, revenues slightly declined, dropping to $42,857 million in 2023 before stabilizing at $42,879 million in 2024.
- Operating Income
- Operating income shows a consistent growth pattern from 2005 ($263 million) to 2021 ($10,028 million), displaying increasing profitability alongside revenue growth. There was a sharp rise in operating income between 2006 and 2007, from $242 million to $974 million, paralleling the revenue jump. Operating income reached its highest point in 2021 before declining to $6,859 million in 2022 and slightly recovering to $7,337 million in 2024. This indicates some pressure on operating profitability in the most recent years despite stable revenues.
- Net Income Attributable to Thermo Fisher Scientific Inc.
- Net income follows a similar upward trajectory as operating income, increasing from $223 million in 2005 to a peak of $7,725 million in 2021. This growth reflects effective management of expenses and taxes alongside strong operational performance. Despite the peak in 2021, net income declined in 2022 and 2023 to $6,950 million and $5,995 million respectively, before partially rebounding to $6,335 million in 2024. The decline post-2021 may suggest challenges such as increased costs, lower margins, or other financial pressures impacting profitability.
In summary, the data indicates a strong long-term growth trend in revenues, operating income, and net income, with rapid expansions especially noticeable in the early years and from 2014 to 2021. However, the period after 2021 shows a downturn in both operating and net income despite relatively stable revenues, signaling potential emerging profitability challenges that warrant further investigation.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Current assets
-
The current assets exhibit a generally increasing trend over the analyzed period from 2005 through 2024. Starting at approximately 1,354 million US dollars in 2005, current assets grow significantly to reach a peak of around 25,229 million US dollars by the end of 2022. This total then slightly decreases in 2023 and 2024 to approximately 24,589 million and 22,137 million US dollars respectively.
Within this timeframe, notable increments occurred between 2012 and 2013, where current assets nearly doubled from around 4,835 million to 9,881 million US dollars, indicating a substantial increase in liquidity or short-term resources available to the company. A similar significant surge is visible between 2019 and 2020, jumping from approximately 11,893 million to 21,957 million US dollars, more than an 80% increase. Following this spike, current assets fluctuate but remain at elevated levels compared to earlier years.
These patterns suggest periods of increased short-term asset accumulation which might be linked to operational growth, acquisitions, or other strategic financial management decisions aimed at strengthening the company's position to meet short-term obligations.
- Total assets
-
Total assets also display a strong upward trend over the period from 2005 to 2024. Beginning at 4,252 million US dollars in 2005, total assets escalate considerably, reaching approximately 97,726 million US dollars in 2023 before a slight decline to 97,321 million US dollars in 2024.
The data reveal a continuous asset base expansion, with few minor fluctuations, particularly notable between 2006 and 2007 where total assets remain relatively stable near 21,200 million US dollars. From 2012 onwards, total assets increase steadily, exceeding 56,000 million US dollars by the end of 2017 and continuing to climb thereafter.
The most pronounced growth occurs between 2019 and 2023, where total assets nearly double from approximately 58,381 million to over 97,000 million US dollars. This substantial growth indicates significant investments in asset acquisitions, perhaps through capital expenditures, mergers, or intensified operational capacity.
The mild decrease observed in 2024 suggests a possible asset revaluation, disposals, or a more conservative asset management approach following several years of pronounced expansion.
- Trend Summary
-
Overall, both current assets and total assets reveal a strong, sustained growth trajectory over nearly two decades, reflecting the company’s expanding scale and capital base. Sudden increases in current assets at specific intervals may indicate strategic liquidity management or operational shifts, while the growth in total assets underscores ongoing investments and business expansion.
The slight reductions observed at the end of the period for both asset categories could suggest adjustments in financial structure or asset composition, which may warrant further investigation to understand the underlying causes.
Balance Sheet: Liabilities and Stockholders’ Equity
Thermo Fisher Scientific Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total obligations | Total Thermo Fisher Scientific Inc. shareholders’ equity | |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Current liabilities
- The current liabilities show a general upward trend over the examined period, increasing substantially from 792 million USD at the end of 2005 to a peak of 17,010 million USD in 2022. There are notable fluctuations, including significant rises in the years to 2010 and sharp increases again around 2014 and from 2019 to 2022. Following the 2022 peak, a decline is observed, with current liabilities decreasing to 14,012 million USD in 2023 and further to 13,332 million USD in 2024.
- Total obligations
- Total obligations have demonstrated a marked increase overall, beginning at 599 million USD in 2005 and reaching a maximum of 34,917 million USD in 2023. The growth pattern includes several episodes of rapid escalation, particularly between 2010 and 2013, and again from 2016 onward. After attaining the peak in 2023, a decline is observed in 2024, where total obligations fall to 31,275 million USD. Despite this recent decrease, the overall trend is one of increasing obligations.
- Total shareholders’ equity
- Shareholders’ equity has shown consistent growth throughout the period, rising steadily from 2,793 million USD at the end of 2005 to 49,584 million USD in 2024. This reflects a robust increase in equity value without evident setbacks or declines across the years. The growth appears linear with some acceleration in the later years, particularly from 2016 through 2024.
- Overall insights
- The data reveals substantial expansion in the scale of liabilities and equity alike, indicative of business growth and increased financial activity. While both current liabilities and total obligations have risen notably, the growth in shareholders’ equity suggests the company has been able to increase its book value, potentially through retained earnings and capital contributions. The recent declines in current liabilities and total obligations after their peaks could indicate efforts to reduce leverage or improved working capital management. The upward trend in equity reinforces financial stability and the potential for continued investment and expansion.
Cash Flow Statement
Thermo Fisher Scientific Inc., selected items from cash flow statement, long-term trends
US$ in millions
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The company's cash flow activities over the reported periods exhibit distinct trends across operating, investing, and financing activities, reflecting the dynamic financial strategies and external conditions affecting the business.
- Operating Activities
-
Net cash provided by operating activities shows a general upward trajectory from 2005 through 2024, indicating improvement and growth in the company’s core business cash generation. Starting at $273 million in 2005, operating cash flows increased substantially to a peak around 2021 with $9,312 million. While there were minor fluctuations, such as a dip from 2017 to 2019, the overall trend is positive, suggesting robust operational efficiency and revenue-generating capability.
- Investing Activities
-
Net cash used in investing activities presents a predominantly negative pattern, indicating consistent capital expenditures or acquisitions. Voids in positive values are rare, with most years reflecting negative cash outflows. The magnitude of investing cash outflows fluctuated significantly, such as the extreme outflow of $11,783 million in 2013 and an even larger outflow of $21,932 million in 2021. This shows periods of aggressive investment or notable asset purchases. There are some years with relatively lower negative values or even a positive figure early in the timeline (2006), but overall investing activities contribute to cash consumption rather than generation.
- Financing Activities
-
Net cash flows from financing activities are volatile, with alternating inflows and outflows reflecting changing financing strategies and market conditions. Notable inflows occurred in years like 2012 ($3,551 million), 2014 ($4,796 million), 2017 ($3,854 million), and especially in 2021 ($6,581 million), likely indicating raising capital through debt or equity. Conversely, there are significant outflows, such as in 2015 (-$2,491 million), 2018 (-$2,237 million), and more sharply negative values in 2023 and 2024 (-$3,622 million and -$6,792 million, respectively), possibly tied to debt repayments, dividends, or share repurchases. This volatility suggests responsive financial management adapting to operational and investment needs.
In summary, the operating cash flow trend reflects strengthening business performance, while investment cash flow consistently absorbs substantial cash resources indicative of growth initiatives or asset acquisitions. Financing cash flows fluctuate considerably, showing adaptive capital structure management to support both operations and investments. The interplay among these three cash flow activities highlights an active approach to sustaining long-term growth despite episodic fluctuations and large capital commitments.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The analysis of the earnings per share (EPS) data indicates a general upward trajectory over the two-decade period, with some fluctuations in between. Basic EPS started at 1.38 US dollars in 2005, experiencing a decline to 0.86 US dollars in 2006 before recovering and demonstrating consistent growth. Notable increases occurred from 2013 onwards, culminating in a peak of 19.62 US dollars in 2021. A decrease followed in 2022 to 17.75 US dollars and further to 15.52 US dollars in 2023, with a slight rebound to 16.58 US dollars projected for 2024. The diluted EPS follows a very similar pattern, confirming the consistency of earnings performance across both basic and diluted measures.
The dividend per share data, available from 2013 onwards, shows a steady increase without interruption. Initial reporting of dividends at 0.54 US dollars per share in 2013 increased incrementally each year, reaching 1.56 US dollars in 2024. This suggests a deliberate and sustained policy of returning value to shareholders, aligned with the growth in earnings.
- Basic Earnings Per Share (EPS)
- The EPS showed some volatility in the earlier years with a notable dip in 2006 but overall trended upwards significantly in the medium and long term. The period from 2013 to 2021 saw rapid growth, particularly strong between 2018 and 2021. Earnings contracted slightly after 2021 but remained at historically high levels compared to the early period.
- Diluted Earnings Per Share
- This metric closely mirrored the basic EPS trends, reinforcing the reliability of earnings growth and indicating limited dilution effects on shareholder value. The growth pattern and recent declines parallel those observed in basic EPS.
- Dividend Per Share
- Dividends began being paid in 2013 and increased annually in a steady fashion through to 2024. This gradual increase in dividends corresponds with rising earnings, reflecting a policy of distributing a growing portion of profits to shareholders.